KRS 196.288: Allocations of funding to certain funds and programs.
Where this section sits in the code
- KRS Chapter 196
Beginning in fiscal year 2026 -2027, the following amounts shall be allocated or
distributed by the secretary of the Justice and Public Safety Cabinet:
(1) Four million six hundred thirty thousand two hundred dollars ($4,630,200) shall be
distributed to the local corrections assistance fund established by KRS 441.207; and
(2) Sixteen million three hundred eighty -three thousand five hundred dollars
($16,383,500) shall be distributed for the following purposes:
(a) To the department to provide or to contract f or the provision of substance
abuse treatment in county jails, regional jails, or other local detention centers
that employ evidence -based practices in behavioral health treatment or
medically assisted treatment for nonstate inmates with opiate addiction o r
other substance abuse disorders;
(b) For KY-ASAP programs operating under KRS Chapter 15A in county jails or
in facilities under the supervision of county jails that employ evidence -based
behavioral health treatment or medically assisted treatment for in mates with
opiate addiction or other substance abuse disorders;
(c) To KY -ASAP to provide supplemental grant funding to community mental
health centers for the purpose of offering additional substance abuse treatment
resources through programs that employ evidence-based behavioral health
treatment or medically assisted treatment;
(d) To KY -ASAP to address neonatal abstinence syndrome by providing
supplemental grant funding to community substance abuse treatment
providers to offer residential treatment servi ces to pregnant women through
programs that employ evidence -based behavioral health treatment or
medically assisted treatment;
(e) To provide supplemental funding for traditional KY -ASAP substance abuse
programming under KRS Chapter 15A;
(f) To the departm ent for the purchase of FDA -approved medication -assisted
treatment products as a component of evidence -based treatment for inmates
with opioid dependence, opioid use disorder, or other substance abuse
disorders, for use in substance abuse treatment program s operated or
supervised by the department. In purchasing such FDA -approved products,
the department shall consider products and treatments that may minimize the
risk of diversion;
(g) To the Department of Public Advocacy to provide supplemental funding to
the Social Worker Program for the purpose of creating additional social
worker positions to develop individualized alternative sentencing plans; and
(h) To the Prosecutors Advisory Cou ncil to enhance the use of rocket docket
prosecutions in controlled substance cases.
Collected 2026-09-05T20:51:49Z. Source file · JSON